# OnCo record nilutamide (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/nilutamide/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "nilutamide" ;
  schema:name "Nilutamide"@en ;
  schema:alternateName "Anandron"@en, "Nilandron" ;
  schema:description "Nilutamide (Nilandron) is an older antiandrogen tablet started on the day of surgical castration for metastatic prostate cancer; it is rarely used now because of lung and eye side effects."@en ;
  schema:url <https://onco.cc/drugs/nilutamide/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Nilutamide> ;
  schema:citation <https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=nilutamide>, <https://www.cancer.gov/about-cancer/treatment/drugs/nilutamide> ;
  onco:status "approved" ;
  onco:tag "nci-list", "generic" ;
  onco:modality "Non-steroidal antiandrogen (first generation)" ;
  onco:approval "US 1996: Metastatic (stage D2) prostate cancer in combination with surgical castration" ;
  onco:related <https://onco.cc/drugs/flutamide/>, <https://onco.cc/drugs/bicalutamide/> ;
  onco:cancers <https://onco.cc/cancers/prostate/> ;
  onco:technologies <https://onco.cc/technologies/androgen-deprivation/> ;
  onco:targets <https://onco.cc/targets/androgen-receptor/> ;
  onco:trials <https://onco.cc/trials/nct03678025/>, <https://onco.cc/trials/nct00003653/>, <https://onco.cc/trials/nct00002633/> .